10967/169 - QDB Compounds

QsarDB Repository

Oliveira, K. M. G.; Takahata, Y. QSAR Modeling of Nucleosides Against Amastigotes of Leishmania donovani Using Logistic Regression and Classification Tree. QSAR Comb. Sci. 2008, 27, 1020–1027.

35 compounds | Property Activity: Activity against Leishmania donovani

IDNameActivityDetails
11H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iactiveView
21-[(2R)-oxolan-2-yl]-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iinactiveView
31-[(2R)-oxolan-2-yl]-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-amine iinactiveView
46-(methylsulfanyl)-1-[(2R)-oxolan-2-yl]-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iinactiveView
56-amino-1-[(2R)-oxolan-2-yl]-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iinactiveView
61-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(methylsulfanyl)-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iactiveView
76-amino-1-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iinactiveView
81-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(methylsulfanyl)-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iactiveView
96-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iinactiveView
106-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iinactiveView
116-amino-1-[(2R,3S,4R,5R)-3,4-bis(benzyloxy)-5-[(benzyloxy)methyl]oxolan-2-yl]-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iactiveView
121-[(2S,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(methylsulfanyl)-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iactiveView
136-amino-1-[(2S,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iactiveView
141-[(2S,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(methylsulfanyl)-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iactiveView
156-amino-1-[(2S,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iactiveView
161-[(2-hydroxyethoxy)methyl]-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iinactiveView
172-({4-amino-1H-pyrazolo[3,4-d]pyrimidin-1-yl}methoxy)ethan-1-ol iactiveView
182-({4-oxo-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-1-yl}methoxy)ethyl benzoate iactiveView
191-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iactiveView
202-({4-amino-1H-pyrazolo[3,4-d]pyrimidin-1-yl}methoxy)propane-1,3-diol iinactiveView
211-{[(1-amino-3-hydroxypropan-2-yl)oxy]methyl}-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iactiveView
226-amino-1-[(2-hydroxyethoxy)methyl]-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one iactiveView
234-amino-1-[(2-hydroxyethoxy)methyl]-1H,6H,7H-pyrazolo[3,4-d]pyrimidin-6-one iactiveView
242-amino-9-[(2-hydroxyethoxy)methyl]-6,9-dihydro-1H-purin-6-one iinactiveView
252-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-1H-purin-6-one iinactiveView
26(2R,3S,4R,5S)-2-{7-amino-1H-pyrazolo[4,3-d]pyrimidin-3-yl}-5-(hydroxymethyl)oxolane-3,4-diol iactiveView
273-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H,6H,7H-pyrazolo[4,3-d]pyrimidin-7-one iactiveView
287-[(2R,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-4-one iactiveView
296-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H,4H,5H-imidazo[4,5-c]pyridin-4-one iactiveView
309-[(2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one iactiveView
311H,4H,5H-pyrazolo[3,4-d]pyrimidine-4-thione iactiveView
321-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H,4H,5H-pyrazolo[3,4-d]pyrimidine-4-thione iactiveView
333-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,6H,7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one iactiveView
347-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,4H-thieno[3,2-d]pyrimidin-4-one iactiveView
357-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,4H,7H-pyrrolo[2,3-d]pyrimidin-4-one iactiveView

Bibliography

  1. Hasan, A.; Tripathi, R. P.; Pratap, R.; Bhakuni, D. S.; Pal, R.; Mishra, A.; Guru, P. Y.; Katiyar, J. C. Studies on nucleosides. Part XX. Synthesis and antileishmanial activity of 4,6-substituted pyrazolo[3,4-d]pyrimidine nucleosides. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry 1989, 28B, 403-409.

  2. Khan, S. I.; Mishra, A.; Guru, P. Y.; Pratap, R.; Bhakuni, D. S. Studies in nucleosides. Part XXV. Synthesis of alicyclic and cyclic nucleosides of 4(5H)-oxopyrazolo[3,4-d]pyrimidine and 4-aminopyrazolo[3,4-d]pyrimidine and their antileishmanial activity. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry 1990, 29B, 40-46.